PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Junxiong Wen

Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

AUG 26, 2026 · JOURNAL ARTICLE

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International Journal of Pharmaceutics: X

A comprehensive review synthesizing current knowledge on biomaterial-based drug delivery for head and neck cancer, identifying clinical challenges and therapeutic opportunities without presenting original experimental data or clinical trial results.

Expert GuidanceJunxiong Wen Combination Therapy Xiao Cui

Reported

HNSCC and OSCC proportion of HNCapproximately 90%

5-year survival rate for advanced…50–60%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support